Načítá se...
Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease
INTRODUCTION: Controversies regarding the use of beta-blocker in COPD have been longstanding and based on inconsistent data. COPD and cardiovascular disease have many shared risk factors and potentially overlapping pathophysiologic mechanisms. Beta-blockers, a mainstay of treatment in ischemic heart...
Uloženo v:
| Vydáno v: | Expert Rev Respir Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7365250/ https://ncbi.nlm.nih.gov/pubmed/32250198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17476348.2020.1752671 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|